Advertisement

Sa1981 COMPARISON OF THE EFFICACY AND SAFETY OF THE FDA-APPROVED BARIATRIC ENDOSCOPIC THERAPIES IN A CLINICAL SETTING

      Obesity is a national epidemic associated with morbidity and mortality. FDA-approved endoscopic treatments for obesity are the gastric balloon systems (ReShape, Orbera, and Obalon), the gastric aspiration system (AspireAssist), and endoscopic sleeve gastroplasty (ESG; Overstitch). It is unknown how these therapies compare in real world practice.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect